Cargando…
Receptor tyrosine kinase ROR1 ameliorates Aβ(1–42) induced cytoskeletal instability and is regulated by the miR146a-NEAT1 nexus in Alzheimer’s disease
Alzheimer’s disease (AD) involves severe cytoskeletal degradation and microtubule disruption. Here, we studied the altered dynamics of ROR1, a Receptor Tyrosine Kinase (RTK), and how it could counter these abnormalities. We found that in an Aβ(1–42) treated cell model of AD, ROR1 was significantly d...
Autores principales: | Chanda, Kaushik, Jana, Nihar Ranjan, Mukhopadhyay, Debashis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479066/ https://www.ncbi.nlm.nih.gov/pubmed/34584188 http://dx.doi.org/10.1038/s41598-021-98882-0 |
Ejemplares similares
-
A nexus of miR-1271, PAX4 and ALK/RYK influences the cytoskeletal architectures in Alzheimer's Disease and Type 2 Diabetes
por: Majumder, Piyali, et al.
Publicado: (2021) -
Construction and Stable Expression of a Truncated Human Receptor Tyrosine Kinase Ror1 (Ror1-ECD)
por: Forouzesh, Flora, et al.
Publicado: (2012) -
Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells
por: Hojjat-Farsangi, Mohammad, et al.
Publicado: (2013) -
Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies
por: Zhao, Yuming, et al.
Publicado: (2021) -
Retraction: Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells
Publicado: (2022)